CLOV
Clover Health·NASDAQ
--
--(--)
--
--(--)
4.84 / 10
Netural
Fund flow is good (7.68/10) with ~48% inflow across all size brackets, though trends are negative. Analyst sentiment is split: one Strong Buy, one Neutral, with low historical win rates, yielding a neutral overall outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-20
InstitutionCanaccord Genuity
Times predicted4
Historical Win Rate25.0%
What is the analyst consensus for CLOV?
- CLOV holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.84/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
